Prescription drug · ANDA
Metoprolol succinate NDC 72516-026
Metoprolol succinate 50 mg/1 · Tablet, Extended release · Oral · Oryza pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72516-026-01 | 7251600260172516002601 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-026-01)Marketed from Jul 21, 2025 | |
| 72516-026-10 | 7251600261072516002610 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-026-10)Marketed from Jul 21, 2025 | |
| 72516-026-50 | 7251600265072516002650 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-026-50)Marketed from Jul 21, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metoprolol succinate
- Generic name (nonproprietary)
- metoprolol succinate
- Active ingredients
- Metoprolol succinate — 50 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Oryza pharmaceuticals Inc.NDC labeler code 72516
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214110
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 72516-026_5b7d4c2a-8577-3afc-e063-6394a90adbcaSPL ID 5b7d4c2a-8577-3afc-e063-6394a90adbca
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472516002601followed by a unit qualifier and the quantityPackage 72516-0026-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 72516-026
- What is NDC 72516-026?
- 72516-026 is the product NDC for Metoprolol succinate, Metoprolol succinate 50 mg/1 tablet, extended release, listed with the FDA by Oryza pharmaceuticals Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Metoprolol succinate.
- What is the active ingredient?
- Metoprolol succinate.
- Who is the labeler?
- Oryza pharmaceuticals Inc., NDC labeler code 72516. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Metoprolol succinate?
- 250 other product NDCs are listed under this name. See all Metoprolol succinate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Metoprolol succinate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Metoprolol Succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-0883 | 67046-0883-03 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1685 | 67046-1685-03 |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1686 | 67046-1686-03 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Oryza pharmaceuticals Inc. | 72516-025 | 72516-0025-0172516-0025-1072516-0025-50 |
| Metoprolol Succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-684 | 68001-0684-0068001-0684-03 |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-685 | 68001-0685-0068001-0685-03 |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-686 | 68001-0686-0068001-0686-03 |
| Metoprolol Succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-687 | 68001-0687-00 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1650 | 67046-1650-03 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | Aphena Pharma Solutions - Tennessee, LLC | 53401-009 | 53401-0009-3053401-0009-4553401-0009-53+3 more |
Other NDCs under ANDA 214110
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1685 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 71335-3167 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Zhejiang Jutai Pharamceutical Co., Ltd | 71765-006 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Zhejiang Jutai Pharamceutical Co., Ltd | 71765-007 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Zhejiang Jutai Pharamceutical Co., Ltd | 71765-008 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Oryza pharmaceuticals Inc. | 72516-025 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Oryza pharmaceuticals Inc. | 72516-027 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Oryza pharmaceuticals Inc. | 72516-028 |